Cheshire UK, 29 August 2019 BioCity, the pioneering life science incubator and business collective, has today announced investment in precision medicine biotech, Kinomica Ltd., via the Innovate UK Precision Medicine Investment Accelerator. Spun out from Barts Cancer Institute, Queen Mary University of London, Kinomica Ltd is an...
Nottingham, UK – 02 May 2019 BioCity, a pioneering life science incubator and business collective, today announced investment in INCUS Performance, further solidifying their position as a keen investor in promising ventures. Founded in 2016, INCUS Performance is a sports technology start-up that is helping athletes to...
BioCity, Alderley Park based Cresset, innovative provider of software and contract research services for small molecule discovery and design, is pleased to announce that Cancer Research UK Manchester Institute (CRUK MI), has licensed Flare for fresh insights into structure-based drug design. “Putting easy-to use and visually...
Cresset, innovative provider of software and contract research services for small molecule discovery and design, and Elixir Software, provider of real-time workflow tracking applications, have formed an alliance whereby the combination of their technologies will form the basis of a new groundbreaking application, which will radically...
Sygnature Discovery, a leading independent provider of integrated drug discovery and pre-clinical services and expertise, has today announced the next stage in its ambitious expansion plans with the addition of a new facility located at Alderley Park in Cheshire. This expansion will result in the doubling...
Nexus Labs, a pioneering medical education startup, today announced the completion of a Seed funding round to launch its first product, SurgicalTeaching.com a digital platform aimed at enhancing the learning experience of students and doctors around the world. The funding came from the GM&C Life...